EK - Local recommendations (Malignant disease)

Use documents past their review date with caution

Recommendation Approval date Review date
Degarelix prescribing guidelines EKPG April 2015 April 2021
Immunosuppressant Prescribing Update June 2016 June 2019
Oral Methotrexate Kent and Medway Position Statement December 2020 December 2022
  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary